Assessing adolescent immunization options for pertussis in Canada: A cost-utility analysis.

CONCLUSION: Analysis assumes a policy context where immunization of pregnant women is recommended. Findings suggest that alternate adolescent Tdap vaccine strategies - either immunization of 10 year olds, or removal of the adolescent vaccine - are more cost-effective than the current practice of immunizing 14 year olds. PMID: 31889607 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31889607?dopt=Abstract

Source: Vaccine - December 26, 2019 Category: Allergy & Immunology Authors: Anyiwe K, Richardson M, Brophy J, Sander B Tags: Vaccine Source Type: research